- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.08. | HEALTHY EXTRACTS INC.: Healthy Extracts Q2 2026 Net Revenue Up 113% to Record $2.1 Million, Driving Adj. EBITDA of $290,000 or $0.02 per Share | 1.032 | ACCESS Newswire | Strong Growth Outlook Enhanced by Acquisition of Sommer Ray's Imaraïs Beauty, Bringing a New Global Brand Presence Along with Major National and International B2B Wins1H-2026 Net Revenues Reached Record... ► Artikel lesen | |
| 14.08. | HEALTHY EXTRACTS INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 06.08. | HEALTHY EXTRACTS INC.: Healthy Extracts Sees First Half 2026 Net Revenue Up More Than 93% to Record $3.6 Million+ | 546 | ACCESS Newswire | Continued Strong 2026 Outlook Enhanced by Acquisition of Sommer Ray's Imaraïs Beauty, Delivering Major National B2B Customer Wins LAS VEGAS, NV / ACCESS Newswire / August 6, 2026 / Healthy Extracts... ► Artikel lesen | |
| 13.07. | HEALTHY EXTRACTS INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.07. | HEALTHY EXTRACTS INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 21.05. | Healthy Extracts: Imaraïs Beauty Acquisition Expands Reach Into $730 Billion Beauty Market | 1 | pulse2.com | ||
| 19.05. | Healthy Extracts acquires Imaraïs Beauty, raises revenue run-rate outlook | 3 | Seeking Alpha | ||
| 19.05. | Healthy Extracts acquires Imaraïs Beauty for $24M revenue target | 2 | Investing.com | ||
| HEALTHY EXTRACTS Aktie jetzt für 0€ handeln | |||||
| 19.05. | HEALTHY EXTRACTS INC.: Healthy Extracts Acquires Sommer Ray's Global Health & Beauty Brand, Imaraïs Beauty | 864 | ACCESS Newswire | Deal Marks Healthy Extracts' Entrance of $730 Billion Beauty & Personal Care MarketIncreases Company's 2026 Annualized Revenue Run Rate Outlook by 20% to $24 Million HENDERSON, NV / ACCESS Newswire... ► Artikel lesen | |
| 18.05. | HEALTHY EXTRACTS INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Healthy Extracts GAAP EPS of -$0.01, revenue of $1.6M | 1 | Seeking Alpha | ||
| 14.05. | HEALTHY EXTRACTS INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.05. | HEALTHY EXTRACTS INC.: Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA | 508 | ACCESS Newswire | 2026 Outlook Strengthened by New Major Global Partnership with Sommer Ray's Imaraïs Beauty and Entrance into $730 Billion Health & Beauty Market LAS VEGAS, NV / ACCESS Newswire / May 14, 2026 / Healthy... ► Artikel lesen | |
| 16.04. | HEALTHY EXTRACTS INC.: Healthy Extracts' Gummy USA Secures Major U.S. Manufacturing Partnership with Imaraïs Beauty | 515 | ACCESS Newswire | Initial Production Order includes Initial Five SKUs for 4,800+ Premier Isle End-Cap Placements at a Leading National Retailer, Supporting Rapid Expansion in the $720 Billion Health & Beauty Market LAS... ► Artikel lesen | |
| 08.04. | Healthy Extracts Non-GAAP EPS of $0.02 beats by $0.32, revenue of $4.5M misses by $0.59M | 1 | Seeking Alpha | ||
| 08.04. | HEALTHY EXTRACTS INC.: Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million | 574 | ACCESS Newswire | 2025 Non-GAAP Net Income Totaled $162,000 or $0.02 Per ShareRecord Results Driven by Fifth Sequential Quarter of Record-Setting Revenues, with the Momentum Setting Stage for Another Year of Double-Digit... ► Artikel lesen | |
| 02.04. | Healthy Extracts FY25 revenue jumps 45%; 2026 outlook strong | 4 | Seeking Alpha | ||
| 02.04. | HEALTHY EXTRACTS INC.: Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million | 353 | ACCESS Newswire | Strong Annual Results Driven by Record-Setting Revenues for Fifth Quarter in a Row, Setting Stage for Another Record Year in 2026 LAS VEGAS, NV / ACCESS Newswire / April 2, 2026 / Healthy Extracts... ► Artikel lesen | |
| 14.11.25 | HEALTHY EXTRACTS INC.: Healthy Extracts Reports Record Q3 2025, with Revenue up 23% | 583 | ACCESS Newswire | LAS VEGAS, NV / ACCESS Newswire / November 14, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in plant-based nutraceutical innovations, reported results for the third quarter and nine months ended... ► Artikel lesen | |
| 11.11.25 | HEALTHY EXTRACTS INC.: Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025 | 496 | ACCESS Newswire | LAS VEGAS, NV / ACCESS Newswire / November 11, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in science-based nutraceuticals and oral delivery technology for transformational health and longevity... ► Artikel lesen |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TENON MEDICAL | 5,850 | -1,35 % | Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338 | LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain... ► Artikel lesen | |
| FRESENIUS | 45,040 | +0,75 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Graham Doyle hält die Sorgen um das US-Geschäft mit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,230 | -0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,440 | -0,13 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 27,350 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| BRIGHTSPRING HEALTH SERVICES | 58,73 | 0,00 % | BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell? | ||
| LIFESTANCE HEALTH GROUP | 12,975 | +0,04 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 49,850 | -0,06 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 12,610 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| CARL ZEISS MEDITEC | 30,300 | -2,38 % | 589 Millionen Menschen mit Diabetes: Warum die globale Diabetes-Welle zum Technologiethema für die Augen wird - und wo Rise Nano Optics ins Spiel kommt | ||
| AVEANNA HEALTHCARE | 14,060 | -0,14 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,370 | -0,15 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| GERRESHEIMER | 28,220 | -2,62 % | EQS-DD: Gerresheimer AG: Active Ownership Opportunities SCS, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
07.09.2026 / 15:24... ► Artikel lesen | |
| GENEDX | 85,16 | -0,12 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| PRIVIA HEALTH GROUP | 20,420 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |
HEALTHY EXTRACTS INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HEALTHY EXTRACTS INC finden Sie auf Wallstreet Online.